Effects of rizatriptan on the contingent negative variation in healthy women

Cephalalgia

Volumn 28, Issue 9, 2008, Pages 922-932

  Zank, R ^a   Strehl, U ^a   Larbig, W ^a   Kotchoubey, B ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Contingent negative variation; Cortical excitability; Healthy; Migraine; Triptan

Indexed keywords

PLACEBO; RIZATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTINGENT NEGATIVE VARIATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HABITUATION; HUMAN; HUMAN EXPERIMENT; MIGRAINE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; REACTION TIME;

ADULT; AROUSAL; CONTINGENT NEGATIVE VARIATION; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; MODELS, NEUROLOGICAL; REFERENCE VALUES; SEROTONIN; SEROTONIN AGONISTS; TRIAZOLES; TRYPTAMINES;

EID: 49649116138     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01624.x     Document Type: Article

References (58)

1. Welch KM. Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention. Headache 2005 45 (Suppl. 1 25 32.
2. Schoenen J. Abnormal cortical information processing between migraine attacks. In : Sandler M, Ferrari M, Harnet S, eds. Migraine pharmacology and genetics. London : Chapman & Hall 1996 : 233 46.
3. Ambrosini A, Maertens de Noordhout A, Sandor PS, Schoenen J. Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia 2003 23 (Suppl. 1 13 31.
4. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia 2004 24 (Suppl. 2 2 7.
5. Bohotin V, Fumal A, Vandenheede M, Gerard P, Bohotin C, Maertens de Noordhout A, Schoenen J. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain 2002 125 : 912 22.
6. Walter WG, Cooper R, Aldridge VJ, McCallum WC, Winter AL. Contingent negative variation: an electrical sign of sensori-motor association and expectancy in the human brain. Nature 1964 203 : 380 4.
7. Rockstroh B, Elbert T, Canavan A, Lutzenberger W, Birbaumer N. Slow cortical potentials and behavior. München : Urban & Schwarzenberg 1989.
8. Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M. Contingent negative variation (CNV) as a diagnostic and physiopathologic tool in headache patients. In : Clifford R, editor. Migraine. Proceedings of the 5th international migraine symposium, London 1984. Basel : Karger 1985.
9. Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M. Contingent negative variation and efficacy of beta-blocking agents in migraine. Cephalalgia 1986 6 : 229 33.
10. Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J. Contingent negative variation in headache. Ann Neurol 1986 19 : 78 80.
11. Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J. Effects of β-blockade on contingent negative variation in migraine. Ann Neurol 1987 21 : 111 12.
12. Böcker KBE, Timsit-Berthier M, Schoenen J, Brunia CHM. Contingent negative variation in migraine. Headache 1990 30 : 604 9.
13. Kropp P, Gerber WD. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 1995 15 : 123 8.
14. Kropp P, Gerber WD. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation. Neurosci Lett 1998 257 : 73 6.
15. Siniatchkin M, Gerber WD, Kropp P, Vein A. Contingent negative variation in patients with chronic daily headache. Cephalalgia 1998 18 : 565 9.
16. Kropp P, Kirbach U, Detlefsen JO, Siniatchkin M, Gerber WD, Stephani U. Slow cortical potentials in migraine: a comparison of adults and children. Cephalalgia 1999 19 (Suppl. 25 60 4.
17. Kropp P, Siniatchkin M, Stephani U, Gerber WD. Migraine - evidence for a disturbance of cerebral maturation in man? Neurosci Lett 1999 276 : 181 4.
18. Siniatchkin M, Gerber WD, Kropp P, Vein A. How the brain anticipates an attack: a study of neurophysiological periodicity in migraine. Funct Neurol 1999 14 : 69 77.
19. Siniatchkin M, Gerber WD, Kropp P, Voznesenskaya T, Vein AM. Are the periodic changes of neurophysiological parameters during the pain-free interval in migraine related to abnormal orienting activity? Cephalalgia 2000 20 : 20 9.
20. Siniatchkin M, Kropp P, Gerber WD. Contingent negative variation in subjects at risk for migraine without aura. Pain 2001 94 : 159 67.
21. Kropp P, Siniatchkin M, Gerber WD. Contingent negative variation as indicator of duration of migraine disease. Funct Neurol 2000 15 (Suppl. 3 78 81.
22. Kropp P, Gerber WD. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 1993 13 : 37 41.
23. Göbel H, Krapat S, Ensink FBM, Soyka D. Comparison of contingent negative variation between migraine interval and migraine attacks before and after treatment with sumatriptan. Headache 1993 33 : 570 2.
24. Faran S. Pharmacological and psychological approaches on migraine treatment: effects of a calcium antagonist prophylactic medication and of a combined behavioral-hypnosis treatment on clinical parameters and cortical processing in migraine patients. 2002. Doctoral dissertation at the Eberhard-Karls-University of Tübingen, Germany.
25. Mulder EJ, Linssen WH, De Geus EJ. Reduced sensory anticipation in migraine. Psychophysiology 2002 39 : 166 74.
26. Mulder EJ, Linssen WH, Passchier J, De Geus EJ. Interictal and postictal contingent negative variation in migraine without aura. Headache 2001 41 : 72 8.
27. Van der Post J, Schram MT, Schoemaker RC, Pieters MS, Fuseau E, Pereira A et al. CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia 2002 22 : 271 81.
28. Rasmussen BK. Epidemiology of headache. Cephalalgia 2001 21 : 774 7.
29. Chugani DC, Muzik O, Chakraborty PK, Mangner T, Chugani HT. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L- tryptophan. Synapse 1998 28 : 33 43.
30. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997 94 : 5308 13.
31. Barry RJ, Clarke AR, Stuart JJ, Magee CA, Rushby JA. EEG differences between eyes-closed and eyes-open resting conditions. Clin Neurophysiol 2007 118 : 2756 73.
32. Gratton G, Coles MGH, Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 1983 55 : 468 84.
33. Petrinovich L, Widaman KF. An evaluation of statistical strategies to analyze repeated-measures data. In : Peeke HVS, Petrinovich L, eds. Habituation, sensitization and behavior. Orlando, FL : Academic Press Inc. 1984 : 155 201.
34. Van Selst M, Jolicoeur P. A solution to the effect of sample size on outlier elimination. Q J Exp Psychol 1994 47A : 631 50.
35. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ : Prentice Hall 1984 : 261 305.
36. Kropp P, Siniatchkin M, Gerber WD. On the pathophysiology of migraine - links for 'empirically based treatment' with neurofeedback. Appl Psychophysiol Biofeedback 2002 27 : 203 13.
37. Welch KM. The search for a universal hypothesis of migraine mechanisms. The Cummings Lecture. In : Clifford-Rose F, ed. New advances in headache research. Proceedings of the 7th migraine trust international symposium. London : Smith-Gordon 1989 : 15 24.
38. Afra J, Proietti Cecchini A, Sandor PS, Schoenen J. Comparison of visual and auditory evoked cortical potentials in migraine patients between attacks. Clin Neurophysiol 2000 111 : 1124 9.
39. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia 2007 27 : 1295 300.
40. Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996 46 : 1404 9.
41. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993 33 : 173 87.
42. Hegerl U, Juckel G. Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials. World J Biol Psychiatry 2000 1 : 112 18.
43. Judit A, Sandor P, Schoenen J. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia 2000 20 : 714 19.
44. Proietti-Cecchini A, Afra J, Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan. Cephalalgia 1997 17 : 849 54.
45. TM) on central serotonergic neurotransmission as assessed by active oddball auditory event-related potentials in volunteers without migraine. Cephalalgia 1999 19 : 100 6.
46. Roon KI, Sandor PS, Schoonman GG, Lamers FPL, Schoenen J, Ferrari MD, van Dijk JG. Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs. Cephalalgia 1999 19 : 880 5.
47. Elbert T. Slow cortical potentials reflect the regulation of cortical excitability. In : McCallum WC, Curry SH, eds. Slow potentials changes in the human brain. New York : Plenum Press 1993 : 235 51.
48. Nagel-Leiby S, Welch KM, D'Andrea G, Grunfeld S, Brown E. Event-related slow potentials and associated cathecolamine function in migraine. Cephalalgia 1990 10 : 317 29.
49. Siniatchkin M, Averkina N, Gerber WD. Relationship between precipitating agents and neurophysiological abnormalities in migraine. Cephalalgia 2006 26 : 457 65.
50. Kaneda Y, Ikuta T, Nakayama H, Kagawa K, Furuta N. Visual evoked potential and electroencephalogram of healthy females during the menstrual cycle. J Med Invest 1997 44 : 41 6.
51. Tasman A, Hahn T, Maiste A. Menstrual cycle synchronized changes in brainstem auditory evoked potentials and visual evoked potentials. Biol Psychiatry 1999 45 : 1516 19.
52. Fleck KM, Polich J. P300 and the menstrual cycle. Electroencephalogr Clin Neurophysiol 1988 71 : 157 60.
53. Ehlers CL, Phillips E, Parry BL. Electrophysiological findings during the menstrual cycle in women with and without late luteal phase dysphoric disorder: relationship to risk for alcoholism? Biol Psychiatry 1996 39 : 720 32.
54. Kluck N, O'Connor S, Hesselbrock V, Tasman A, Maier D, Bauer L. Variation in evoked potential measures over the menstrual cycle: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 1992 16 : 901 11.
55. Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990 28 : 597 613.
56. Dobson CF, Tohyama Y, Diksic M, Hamel E. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 2004 24 : 2 11.
57. 1 autoreceptors: parallel purposes or pointless plurality? Trends Neurosci 2000 23 : 459 65.
58. Fumal A, Coppola G, Bohotin V, Gérardy P-Y, Seidel L, Donneau A-F et al. Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients. Cephalalgia 2006 26 : 143 9.